• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠类器官形态分析(ROMA)作为囊性纤维化有前途的诊断工具。

Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis.

机构信息

Department of Development and Regeneration, Woman and Child Unit, CF Research Lab, KU Leuven, Leuven, Flanders, Belgium.

Department of Pediatrics, Pediatric Pulmonology, University Hospital of Leuven, Leuven, Flanders, Belgium.

出版信息

Thorax. 2021 Nov;76(11):1146-1149. doi: 10.1136/thoraxjnl-2020-216368. Epub 2021 Apr 15.

DOI:10.1136/thoraxjnl-2020-216368
PMID:33859053
Abstract

Diagnosing cystic fibrosis (CF) when sweat chloride is not in the CF range and less than 2 disease-causing mutations are found requires physiological CFTR assays, which are not always feasible or available. We developed a new physiological CFTR assay based on the morphological differences between rectal organoids from subjects with and without CF. In organoids from 167 subjects with and 22 without CF, two parameters derived from a semi-automated image analysis protocol (rectal organoid morphology analysis, ROMA) fully discriminated CF subjects with two disease-causing mutations from non-CF subjects (p<0.001). ROMA, feasible at all ages, can be centralised to improve standardisation.

摘要

当汗液氯化物不在 CF 范围内且发现的致病突变少于 2 个时,需要进行生理 CFTR 检测,但这些检测并不总是可行或可用。我们开发了一种新的生理 CFTR 检测方法,该方法基于 CF 患者和非 CF 患者直肠类器官之间的形态差异。在来自 167 名 CF 患者和 22 名非 CF 患者的类器官中,从半自动化图像分析协议(直肠类器官形态分析,ROMA)中得出的两个参数能够完全区分出有两个致病突变的 CF 患者和非 CF 患者(p<0.001)。ROMA 适用于所有年龄段,可集中进行以提高标准化程度。

相似文献

1
Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis.直肠类器官形态分析(ROMA)作为囊性纤维化有前途的诊断工具。
Thorax. 2021 Nov;76(11):1146-1149. doi: 10.1136/thoraxjnl-2020-216368. Epub 2021 Apr 15.
2
Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis.直肠类器官形态分析(ROMA)作为一种新型的生理检测方法,可用于囊性纤维化的诊断分类。
Thorax. 2024 Aug 19;79(9):834-841. doi: 10.1136/thorax-2023-220964.
3
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.在肠道类器官中纠正 CFTR 功能以指导囊性纤维化的治疗。
Eur Respir J. 2021 Jan 5;57(1). doi: 10.1183/13993003.02426-2019. Print 2021 Jan.
4
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.使用源自囊性纤维化患者的直肠类器官来描述 CFTR 调节剂药物的反应。
Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.
5
Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis.S1251N 等位基因在囊性纤维化中的严重程度受顺式存在 F508C 变体的影响。
J Cyst Fibros. 2022 Jul;21(4):644-651. doi: 10.1016/j.jcf.2022.05.013. Epub 2022 Jun 9.
6
Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.利用干细胞衍生类器官进行囊性纤维化 CFTR 变异体的药物分析。
Drug Discov Today. 2019 Nov;24(11):2126-2138. doi: 10.1016/j.drudis.2019.05.029. Epub 2019 Jun 4.
7
Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients.鉴定保加利亚人、保加利亚土耳其人和罗姆人囊性纤维化患者中 99% 的 CFTR 基因突变。
Mol Genet Genomic Med. 2019 Aug;7(8):e696. doi: 10.1002/mgg3.696. Epub 2019 Jun 27.
8
Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.囊性纤维化跨膜传导调节因子(CFTR)突变分析在囊性纤维化诊断流程中的作用。
World J Pediatr. 2017 Apr;13(2):129-135. doi: 10.1007/s12519-017-0015-8. Epub 2017 Feb 15.
9
Pancreatic duct organoid swelling is chloride-dependent.胰腺导管类器官肿胀依赖于氯离子。
J Cyst Fibros. 2024 Jan;23(1):169-171. doi: 10.1016/j.jcf.2023.08.003. Epub 2023 Aug 24.
10
β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.β2-肾上腺素能受体激动剂激活肠类器官和囊性纤维化患者中的 CFTR。
Eur Respir J. 2016 Sep;48(3):768-79. doi: 10.1183/13993003.01661-2015. Epub 2016 Jul 28.

引用本文的文献

1
Organoids in Genetic Disorders: from Disease Modeling to Translational Applications.遗传性疾病中的类器官:从疾病建模到转化应用
Stem Cell Rev Rep. 2025 Sep 11. doi: 10.1007/s12015-025-10973-x.
2
The Promising Role of Intestinal Organoids in the Diagnostic Work-Up of Cystic Fibrosis Screen Positive Inconclusive Diagnosis/CFTR-Related Metabolic Syndrome (CFSPID/CRMS).肠道类器官在囊性纤维化筛查阳性但诊断不确定/囊性纤维化跨膜传导调节因子相关代谢综合征(CFSPID/CRMS)诊断检查中的前景作用
Int J Neonatal Screen. 2025 Jul 11;11(3):52. doi: 10.3390/ijns11030052.
3
Biomedical applications of organoids in genetic diseases.
类器官在遗传疾病中的生物医学应用。
Med Rev (2021). 2024 Dec 24;5(2):152-163. doi: 10.1515/mr-2024-0077. eCollection 2025 Apr.
4
Endometrium-derived organoids from cystic fibrosis patients and mice as new models to study disease-associated endometrial pathobiology.来自囊性纤维化患者和小鼠的子宫内膜来源类器官作为研究疾病相关子宫内膜病理生物学的新模型。
Cell Mol Life Sci. 2025 Mar 13;82(1):109. doi: 10.1007/s00018-025-05627-7.
5
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.调节剂难治性囊性纤维化:定义一个新兴高危人群的范围和挑战。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241297877. doi: 10.1177/17534666241297877.
6
CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids.S737F 和 T465N CFTR 变体在患者来源直肠类器官上对 CFTR 调节剂的反应。
Orphanet J Rare Dis. 2024 Sep 13;19(1):343. doi: 10.1186/s13023-024-03334-3.
7
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.碱基编辑技术可在人类类器官和气道上皮细胞中对导致囊性纤维化的 CFTR 突变进行功能校正。
Cell Rep Med. 2024 May 21;5(5):101544. doi: 10.1016/j.xcrm.2024.101544. Epub 2024 May 1.
8
OrgaSegment: deep-learning based organoid segmentation to quantify CFTR dependent fluid secretion.OrgaSegment:基于深度学习的类器官分割,用于量化 CFTR 依赖性液体分泌。
Commun Biol. 2024 Mar 13;7(1):319. doi: 10.1038/s42003-024-05966-4.
9
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.预测囊性纤维化中CFTR调节剂治疗效果及监测疾病严重程度的实验室工具
J Pers Med. 2024 Jan 13;14(1):93. doi: 10.3390/jpm14010093.
10
CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare Genotypes.在携带有罕见基因型的患者衍生肠类器官中,依伐卡托/泰它卡托/艾氟康唑治疗后 CFTR 功能的恢复。
Int J Mol Sci. 2023 Sep 26;24(19):14539. doi: 10.3390/ijms241914539.